Seemed to me an admission that they are not cost competitive with lime treatment.
Relying on overload 24/7 arguments as to why they should get the business. Of course the competitors could expand in prep also
- Forums
- ASX - By Stock
- NAG
- Ann: PASS Project Update
Ann: PASS Project Update, page-6
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAG (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.002(10.0%) |
Mkt cap ! $15.93M |
Open | High | Low | Value | Volume |
2.0¢ | 2.2¢ | 2.0¢ | $51.16K | 2.411M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 80000 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 364815 | 0.020 |
2 | 582584 | 0.019 |
5 | 530000 | 0.018 |
6 | 846000 | 0.017 |
4 | 3012500 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 862318 | 5 |
0.023 | 275454 | 3 |
0.024 | 937000 | 1 |
0.025 | 217500 | 3 |
0.026 | 1262682 | 3 |
Last trade - 10.18am 12/11/2024 (20 minute delay) ? |
Featured News
NAG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online